Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Nonzee, Narissa J ^a,b   McKoy, June M ^a   Rademaker, Alfred W ^a   Byer, Peter ^a   Luu, Thanh Ha ^a   Liu, Dachao ^a   Richey, Elizabeth A ^c   Samaras, Athena T ^a   Panucci, Genna ^d   Dong, Xinqi ^e   Simon, Melissa A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e RUSH UNIVERSITY   (United States)

Author keywords

Cancer health disparities; Patient navigation; Prostate cancer; Veterans

Indexed keywords

ADVISORY COMMITTEE; AGED; ARTICLE; EARLY DIAGNOSIS; HEALTH CARE DISPARITY; HUMAN; MALE; MANPOWER; METHODOLOGY; MIDDLE AGED; MINORITY GROUP; NEEDS ASSESSMENT; ORGANIZATION AND MANAGEMENT; PATIENT CARE; POVERTY; PROSTATE TUMOR; PSYCHOLOGY; PUBLIC HOSPITAL; REMINDER SYSTEM; SOCIAL WORK; STANDARD; TREATMENT OUTCOME; UNITED STATES;

ADVISORY COMMITTEES; AGED; CHICAGO; EARLY DETECTION OF CANCER; HEALTHCARE DISPARITIES; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; MINORITY GROUPS; NEEDS ASSESSMENT; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT NAVIGATION; POVERTY; PROSTATIC NEOPLASMS; PSYCHOLOGY; REMINDER SYSTEMS; SOCIAL WORK;

EID: 84866544839     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-340     Document Type: Article

References (47)

1. American Cancer Society, Cancer Facts & Figures 2011 Atlanta, GA: American Cancer Society 2011 23205311
2. American Cancer Society, Facts & Figures for African Americans 2011 Atlanta, GA: American Cancer Society 2011 23213431
3. Expanding access to cancer screening and clinical follow-up among the medically underserved. Freeman HP, Muth BJ, Kerner JF, Cancer Pract 1995 3 1 19 30 7704057
4. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Freeman HP, Chu KC, Surg Oncol Clin N Am 2005 14 4 655 669 v 10.1016/j.soc.2005.06.002 16226685 (Pubitemid 41446311)
5. Patient navigation: state of the art or is it science? Wells KJ, Battaglia TA, Dudley DJ, Garcia R, Greene A, Calhoun E, Mandelblatt JS, Paskett ED, Raich PC, Cancer 2008 113 8 1999 2010 10.1002/cncr.23815 18780320
6. National cancer institute patient navigation research program: methods, protocol, and measures. Freund KM, Battaglia TA, Calhoun E, Dudley DJ, Fiscella K, Paskett E, Raich PC, Roetzheim RG, Cancer 2008 113 12 3391 3399 10.1002/cncr.23960 18951521
7. American cancer society guidelines for the early detection of cancer, 2005. Smith RA, Cokkinides V, Eyre HJ, CA Cancer J Clin 2005 55 1 31 44 quiz 55-36 10.3322/canjclin.55.1.31 15661685 (Pubitemid 40310186)
8. Trends in prostate-specific antigen testing from 1995 through 2004. Farwell WR, Linder JA, Jha AK, Arch Intern Med 2007 167 22 2497 2502 10.1001/archinte.167.22.2497 18071173 (Pubitemid 350254910)
9. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, et al. J Natl Cancer Inst 2012 104 2 125 132 10.1093/jnci/djr500 22228146
10. Prostate-cancer mortality at 11 years of follow-up. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, et al. N Engl J Med 2012 366 11 981 990 10.1056/NEJMoa1113135 22417251
11. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Moyer VA, Ann Intern Med 2012 157 2 120 34 22801674
12. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B, JAMA 1995 274 20 1599 1605 10.1001/jama.1995.03530200035033 7474244
13. Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival. Freeman VL, Ricardo AC, Campbell RT, Barrett RE, Warnecke RB, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 20 10 2150 2159 10.1158/1055-9965.EPI-11-0344 23207104
14. Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room? - results from the SEARCH database. Banez LL, Terris MK, Aronson WJ, Presti JC Jr, Kane CJ, Amling CL, Freedland SJ, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 18 4 1208 1212 10.1158/1055-9965.EPI-08-0502 23207104
15. Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems. Freeman VL, Durazo-Arvizu R, Arozullah AM, Keys LC, Am J Public Health 2003 93 10 1706 1712 10.2105/AJPH.93.10.1706 14534226 (Pubitemid 38477639)
16. Racial variation in tumor stage at diagnosis among Department of defense beneficiaries. Enewold L, Zhou J, McGlynn KA, Devesa SS, Shriver CD, Potter JF, Zahm SH, Zhu K, Cancer 2012 118 5 1397 1403 10.1002/cncr.26208 21837685
17. Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal-access health care setting: results from the shared equal access regional cancer hospital (SEARCH) database. Chu DI, Moreira DM, Gerber L, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ, Cancer 2012 10.1002/cncr.27456
18. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J, Carroll PR, Cancer 2007 109 9 1769 1776 10.1002/cncr.22597 17380491 (Pubitemid 46668539)
19. Interventions to improve follow-up of abnormal findings in cancer screening. Bastani R, Yabroff KR, Myers RE, Glenn B, Cancer 2004 101 5 Suppl 1188 1200 15316914 (Pubitemid 39100413)
20. Chronic disease management: what will it take to improve care for chronic illness? Wagner EH, Effective clinical practice: ECP 1998 1 1 2 4 10345255
21. U.S. Department of Veterans Affairs, National Center for Veterans Analysis and Statistics [ http://www.va.gov/vetdata/Veteran-Population.asp ]
22. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. Bennett CL, Ferreira MR, Davis TC, Kaplan J, Weinberger M, Kuzel T, Seday MA, Sartor O, Journal of clinical oncology: official journal of the American Society of Clinical Oncology 1998 16 9 3101 3104 (Pubitemid 28417432)
23. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Wolf MS, Knight SJ, Lyons EA, Durazo-Arvizu R, Pickard SA, Arseven A, Arozullah A, Colella K, Ray P, Bennett CL, Urology 2006 68 1 89 93 10.1016/j.urology.2006.01.064 16844451 (Pubitemid 44037736)
24. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Charlson ME, Pompei P, Ales KL, MacKenzie CR, J Chronic Dis 1987 40 5 373 383 10.1016/0021-9681(87)90171-8 3558716 (Pubitemid 17055592)
25. Development and validation of a short-form, rapid estimate of adult literacy in medicine. Arozullah AM, Yarnold PR, Bennett CL, Soltysik RC, Wolf MS, Ferreira RM, Lee SY, Costello S, Shakir A, Denwood C, et al. Medical care 2007 45 11 1026 1033 10.1097/MLR.0b013e3180616c1b 18049342
26. Perceived stress in a probability sample of the United States. Cohen S, Williamson G, The social psychology of health: Claremont Symposium on applied social psychology Newbury Park, CA: Sage, Spacapam S, Oskamp S, 1988 31 67
27. The MOS social support survey. Sherbourne CD, Stewart AL, Soc Sci Med 1991 32 6 705 714 10.1016/0277-9536(91)90150-B 2035047
28. Development of the multidimensional health locus of control (MHLC) Scales. Wallston KA, Wallston BS, DeVellis R, Health Educ Monogr 1978 6 2 160 170 689890
29. Development and testing of the health care system distrust scale. Rose A, Peters N, Shea JA, Armstrong K, J Gen Intern Med 2004 19 1 57 63 10.1111/j.1525-1497.2004.21146.x 14748861 (Pubitemid 38221952)
30. Development and validation of the communication and attitudinal self-efficacy scale for cancer (CASE-cancer). Wolf MS, Chang CH, Davis T, Makoul G, Patient Educ Couns 2005 57 3 333 341 10.1016/j.pec.2004.09.005 15893217 (Pubitemid 40694014)
31. Impact of event scale: a measure of subjective stress. Horowitz M, Wilner N, Alvarez W, Psychosom Med 1979 41 3 209 218 472086 (Pubitemid 9219271)
32. Structural and reliability analysis of a patient satisfaction with cancer-related care measure: a multisite patient navigation research program study. Jean-Pierre P, Fiscella K, Freund KM, Clark J, Darnell J, Holden A, Post D, Patierno SR, Winters PC, Cancer 2011 117 4 854 861 10.1002/cncr.25501 20922802
33. Psychometric development and reliability analysis of a patient satisfaction with interpersonal relationship with navigator measure: a multi-site patient navigation research program study. Jean-Pierre P, Fiscella K, Winters PC, Post D, Wells KJ, McKoy JM, Battaglia T, Simon MA, Kilbourn K, Psycho-oncology 2012 21 9 986 992 10.1002/pon.2002 21681995
34. A national patient navigator training program. Calhoun EA, Whitley EM, Esparza A, Ness E, Greene A, Garcia R, Valverde PA, Health Promot Pract 2010 11 2 205 215 10.1177/1524839908323521 19116415
35. Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program. Roetzheim RG, Freund KM, Corle DK, Murray DM, Snyder FR, Kronman AC, Jean-Pierre P, Raich PC, Holden AE, Darnell JS, et al. Clin Trials 2012 9 2 176 187 10.1177/1740774511433284 22273587
36. Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues. Ramsey S, Whitley E, Mears VW, McKoy JM, Everhart RM, Caswell RJ, Fiscella K, Hurd TC, Battaglia T, Mandelblatt J, et al. Cancer 2009 115 23 5394 5403 10.1002/cncr.24603 19685528
37. Patient navigation: an update on the state of the science. Paskett ED, Harrop JP, Wells KJ, CA Cancer J Clin 2011 61 4 237 249 10.3322/caac.20111 21659419
38. Increasing prostate cancer screening in African American men with peer-educator and client-navigator interventions. Weinrich SP, Boyd MD, Weinrich M, Greene F, Reynolds WA Jr, Metlin C, Journal of cancer education: the official journal of the American Association for Cancer Education 1998 13 4 213 219 (Pubitemid 29024726)
39. Mortality results from a randomized prostate-cancer screening trial. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, et al. N Engl J Med 2009 360 13 1310 1319 10.1056/NEJMoa0810696 19297565
40. Screening and prostate-cancer mortality in a randomized European study. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, et al. N Engl J Med 2009 360 13 1320 1328 10.1056/NEJMoa0810084 19297566
41. What happens after an elevated PSA test: the experience of 13,591 veterans. Zeliadt SB, Hoffman RM, Etzioni R, Ginger VA, Lin DW, J Gen Intern Med 2010 25 11 1205 1210 10.1007/s11606-010-1468-9 20697965
42. The revolving door of resident continuity practice: identifying gaps in transitions of care. Caines LC, Brockmeyer DM, Tess AV, Kim H, Kriegel G, Bates CK, J Gen Intern Med 2011 26 9 995 998 10.1007/s11606-011-1731-8 21559852
43. Academic year-end transfers of outpatients from outgoing to incoming residents: an unaddressed patient safety issue. Young JQ, Wachter RM, JAMA 2009 302 12 1327 1329 10.1001/jama.2009.1399 19773568
44. Innovative approaches to reducing cancer health disparities: the moffitt cancer center patient navigator research program. Wells KJ, Meade CD, Calcano E, Lee JH, Rivers D, Roetzheim RG, Journal of cancer education: the official journal of the American Association for Cancer Education 2011 26 4 649 657 10.1007/s13187-011-0238-7
45. Understanding variation in primary prostate cancer treatment within the Veterans Health Administration. Nambudiri VE, Landrum MB, Lamont EB, McNeil BJ, Bozeman SR, Freedland SJ, Keating NL, Urology 2012 79 3 537 545 10.1016/j.urology.2011.11.013 22245306
46. Cancer rates, medical comorbidities, and treatment modalities in the oldest patients. Zeber JE, Copeland LA, Hosek BJ, Karnad AB, Lawrence VA, Sanchez-Reilly SE, Crit Rev Oncol Hematol 2008 67 3 237 242 10.1016/j. critrevonc.2008.02.002 18356072
47. Heinzer H, Steuber T: Prostate cancer in the elderly. Urol Oncol 2009, 27(6):668-672.